<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2017</study_start_year><condition>Adenocarcinoma</condition><condition>Colorectal Neoplasms</condition><condition>Colorectal Adenocarcinoma Metastatic to the Liver</condition><disease>Adenocarcinoma</disease><disease>Colorectal Adenocarcinoma Metastatic To The Liver</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2237992</full_dataset_link><location>United States</location><study_start_month>2</study_start_month><keyword>Hepatic Arterial Infusion</keyword><keyword>Irinotecan</keyword><keyword>Dexamethasone</keyword><keyword>Floxuridine (FUDR)</keyword><keyword>Panitumumab</keyword><keyword>Irinotecan (CPT-11)</keyword><keyword>Leucovorin</keyword><keyword>Floxuridine</keyword><keyword>Fluorouracil</keyword><keyword>16-1341</keyword><repository>ECRIN MDR</repository><study_status>Withdrawn</study_status></additional><is_claimable>false</is_claimable><name>Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver</name><description>The purpose of this study is to see if patients treated with both regional chemotherapy using the HAI pump and intravenous chemotherapy are able to have their liver tumors removed surgically (resected), versus treatment with only intravenous chemotherapy.</description><dates><creation>2017-02-15</creation></dates><accession>2237992</accession><cross_references><ClinicalTrials___gov>NCT03069950</ClinicalTrials___gov></cross_references></HashMap>